Tachyphylaxis and Bevacizumab

Ophthalmology

Volumn 116, Issue 9, 2009, Pages 1831-1832

  Avgikos, Konstantinos N ^a   Horgan, Simon E ^a   Sivaraj, Ramesh R ^a   Hu, Kuang ^a  

^a London ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; TRIAMCINOLONE ACETONIDE;

HUMAN; LETTER; MONOTHERAPY; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; TACHYPHYLAXIS; VISUAL ACUITY;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; DRUG THERAPY, COMBINATION; EXUDATES AND TRANSUDATES; HUMANS; INJECTIONS; MACULAR DEGENERATION; RETINA; RETREATMENT; TACHYPHYLAXIS; TOMOGRAPHY, OPTICAL COHERENCE; TRIAMCINOLONE ACETONIDE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VITREOUS BODY;

EID: 69249197004     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2009.03.040     Document Type: Letter

References (1)

1. Schaal S., Kaplan H.J., and Tezel T.H. Is there tachyphylaxis to intravitreal anti-vascular endothelial growth factor pharmacotherapy in age-related macular degeneration?. Ophthalmology 115 (2008) 2199-2205